present a micro-costing analysis that highlights the complexity and the high and variable costs associated with acute and shorter-term outcomes for patients with AKI in critical care.

Kidney International Reports

A cute kidney injury (AKI) is reported to be the most common cause of organ dysfunction in critically ill adults, affecting on the order of 1 in 5 hospitalized patients, with a high mortality rate (20% to 25%), and to present a substantial economic burden for the health care system. In this issue of KI Reports, Mistry et al. present a micro-costing analysis that highlights the complexity and the high and variable costs associated with acute and shorter-term outcomes for patients with AKI in critical care. AKI also has long-term patient and societal outcomes that arguably present greater burdens on patients, carers, and the health care system. In survivors of intensive care units, AKI is independently associated with longer-term mortality, poorer quality of life, frailty, and cardiovascular disease. It has been estimated that

present a micro-costing analysis that highlights the complexity and the high and variable costs associated with acute and shorter-term outcomes for patients with AKI in critical care.

How to Evaluate Interventions for the Treatment and Care of Patients With Acute Kidney Injury